Dosing & Uses
Polycythemia Vera
Pending FDA approval for polycythemia vera
Next:
Pharmacology
Mechanism of Action
Long-acting pegylated interferon alfa-2b
Alfa interferons bind to and activates the human type 1 interferon receptor; signal transduction is initially mediated by the Janus kinase-2 gene (JAK2); polycythemia vera is caused by a JAK2 V617F mutation, that permanently turns of signaling at affected cytokine receptors; this results in overproduction of RBCs by the bone marrow
Previous
Next:
Images
Previous
Next:
Patient Handout
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
